These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18549922)

  • 1. The year in interventional cardiology.
    Dixon SR; Grines CL; O'Neill WW
    J Am Coll Cardiol; 2008 Jun; 51(24):2355-69. PubMed ID: 18549922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interview with Prof. Franz-Joseph Krozingen: Interventional cardiology on the success course].
    Neumann FJ
    MMW Fortschr Med; 2010 Apr; 152(13):18. PubMed ID: 20443337
    [No Abstract]   [Full Text] [Related]  

  • 3. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
    Chhatriwalla AK; Bhatt DL
    Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentation and outcomes.
    Vidi VD; Arora N
    J Invasive Cardiol; 2010 Jun; 22(6):271-2. PubMed ID: 20516506
    [No Abstract]   [Full Text] [Related]  

  • 7. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice.
    Pollack CV; Antman EM; Hollander JE; ;
    Ann Emerg Med; 2008 Oct; 52(4):344-355.e1. PubMed ID: 18519158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiology 2007].
    Hoppe UC; Erdmann E
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1365-7. PubMed ID: 17570081
    [No Abstract]   [Full Text] [Related]  

  • 11. Clopidogrel use in diabetic patients with new stents.
    Cardiovasc J Afr; 2008; 19(4):232. PubMed ID: 18776976
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
    Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
    Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?
    O'Donoghue M; Wiviott SD
    Circulation; 2006 Nov; 114(22):e600-6. PubMed ID: 17130347
    [No Abstract]   [Full Text] [Related]  

  • 15. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
    Simmons BB; Salzman BE
    J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
    [No Abstract]   [Full Text] [Related]  

  • 17. The year in non-ST-segment elevation acute coronary syndromes.
    Giugliano RP; Braunwald E
    J Am Coll Cardiol; 2006 Jul; 48(2):386-95. PubMed ID: 16843191
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
    Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
    Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful clopidogrel desensitization after drug-eluting stent implantation.
    Kammer RT
    J Invasive Cardiol; 2009 Mar; 21(3):134-5. PubMed ID: 19258645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.